ReJuviance Products Corp announced sales of their new topical Ibuprofen Crème were over 400 % higher than expected. It is the only topical ibuprofen crème on the U.S. market. The user adds Ibuprofen - to the transdermal cream and report reduced pain almost immediately.
Online PR News – 20-October-2012 – Sarasota,FL – “Rejuviance Ibuprofen Crème” --- This is a topical anti-inflammatory combining ReJuviance’s optimized transdermal delivery crème and water-dissolved ibuprofen tablets added by the user. Add water, place tablets in water and after they dissolve in 10 minutes, then stir to blend. Temporarily relieves aches and pains for joints and muscles. “This is one of 10 products we have developed containing topical herbal ingredients that have been validated by western science to be effective in improving skin and hair, with early results very positive.Initial sales for the first month since launch are over 400% higher than expected, and consumers are reporting almost immediate reduced pain.” said John Edwards, Co-founder and President of ReJuviance Products Corp.
ReJuviance Products Corp. develops, manufactures and sells rejuvenating topicals that can safely deliver the herbals across the outer skin barrier to the foundation cells that need them. The product family includes rejuvenating topicals that support conventional skin resurfacing surgery, novel topicals that help the body renew skin or hair without triggering the traumatic wound response mechanism, and products that relieve joint and muscle pain or nutritional deficiencies that cause them.
Press Information Only: 941 378 9947
Mr. John Edwards, Rejuviance Products Corp, 6222 Tower Lane B-4, Sarasota, FL 34240
Pilot Study -- In 2010 a clinical study was performed by a research lab on 20 patients for two weeks using an experimental topical Ibuprofen cream. (That study was not performed on the ReJuviance product which was developed later.) That pilot study showed that treatment of chronic knee pain with the topical ibuprofen preparation of their study (which included 4% ibuprofen) provided comparable clinical efficacy and patient satisfaction as oral ibuprofen in that study. (Pain Physician 2010; 13:457-467)